NetScientific PLC NetScientific teams up with KU Leuven (5259B)
07 Janeiro 2015 - 11:04AM
UK Regulatory
TIDMNSCI
RNS Number : 5259B
NetScientific PLC
07 January 2015
NetScientific plc
("NetScientific" or the "Group")
NetScientific teams up with KU Leuven on research programmes in
early cancer detection, epigenomic analysis and fiber-optics
diagnostics
7th January 2015: NetScientific (AIM: NSCI), the biomedical and
healthcare technology group, today announced that it has entered
into three research programmes with KU Leuven in Belgium.
The three programmes focus on the early detection of cancer,
epigenomic analysis, and fiberoptic diagnostics. Details of each
one are given below. The underlying aim of the partnership is to
validate the technologies within each programme and accelerate
their commercialisation.
Early cancer detection
The first programme is developing an innovative multiplex
protein diagnostics solution for the early detection of cancer,
neurodegeneration and infectious diseases.
The primary focus is on the early diagnosis of colorectal cancer
in blood. KU Leuven has patented a panel of 21 protein biomarkers
that can clearly distinguish between healthy people and cancer
patients in the earliest stages of the disease.
The longer term aim of the research programme is to reduce the
21 protein diagnostic panel to a minimal panel of about five
protein markers.
Epigenomic analysis
The next programme is an enzymatic approach to DNA labelling for
epigenomic analysis.
Not all cancers are the result of mutations of DNA but rather
the effect of chemical compounds that modify or mark the genome in
a way that tells it what to do, where to do it and when to do it,
or the 'epigenome'. There is increasing evidence that the epigenome
is both a critical indicator and influencer of the progression of
cancer in response to many factors including ageing, the
environment and diseases.
Epigenomic information is typically difficult and expensive to
read-out and as a result there is a pressing need for the
development of methodology that streamlines this process. KU Leuven
has developed a solution using specially designed cofactor
molecules that can be tailored to capture or label DNA and are
targeted to specific DNA motifs with the supreme specificity of a
selected enzyme.
Fiber optic diagnostics (FOx Dx)
The FOx Dx platform developed at KU Leuven is based on an
innovative fiber optic surface plasmon resonance platform. The
platform allows researchers to optimise their custom bio-assays and
at the same time develop a diagnostic, point-of-care test. It
provides a flexible life science research tool to study
biomolecular kinetics in high throughput analysis.
Commenting on the three programmes, Farad Azima, CEO of
NetScientific said: "These later-stage technologies in diagnostics
and genomics have enormous potential and complement our existing
biomarker-based diagnostics which address the 'personalised
medicine' market."
Paul van Dun, General Manager of KU Leuven R&D, added: "When
talking to potential partners for the further development of our
technologies, we were impressed by the vision and network of
NetScientific. We believe the collaboration with NetScientific
creates an optimal setting for turning the technologies into
products and services that will benefit society."
-Ends-
Notes to Editors
About NetScientific
NetScientific is a biomedical and healthcare technology group
that funds and develops technologies that offer transformative
benefits to people's lives and society through improved diagnosis,
prognosis and treatment. For more information, please visit the
website at www.NetScientific.net
About KU Leuven
Katholieke Universiteit Leuven, founded in 1425, is one of the
oldest universities in Europe and is a world-leader in life
sciences. The research intensive university combines values of high
quality innovation with exceptional facilities, which include a
network of teaching hospitals. The university has a successful
track record in licensing various technologies and novel drug
molecules to major companies around the world.
Contact Details
NetScientific plc Tel: +44 (0) 207
Farad Azima 313 9777
Liberum (NOMAD and Broker) Tel: +44 (0) 20 3100
Chris Bowman / Christopher 2000
Britton
Instinctif Partners Tel: +44 (0) 20 7457
Melanie Toyne-Sewell / 2020 Email: netscientific@instinctif.com
Tim Watson
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCLLFEILDIDIIE
Netscientific (LSE:NSCI)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
Netscientific (LSE:NSCI)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024